Volume of gadolinium enhancement and successful repair of the blood-brain barrier in cerebral adrenoleukodystrophy

Abstract

Up to 40% of boys with adrenoleukodystrophy develop a severe central nervous system demyelinating form (cALD) characterized by white matter changes and gadolinium enhancement on magnetic resonance imaging (MRI). Hematopoietic cell transplant (HCT) is the only proven means to attenuate cALD progression. The elimination of active neuroinflammation is indicated radiographically by the resolution of gadolinium (Gd) enhancement and correlates to speed of donor neutrophil recovery. We analyzed 66 boys with cALD undergoing HCT for biomarkers correlating with early (30 days post-HCT) Gd signal resolution. We found that log Gd volume (cm 3 ) on pre-HCT MRI strongly positively correlated to day 30 Gd resolution ( P = .0003) with smaller volume correlating to higher proportion resolved, as was the baseline gadolinium intensity score ( P = .04), plasma chitotriosidase activity ( P = .04), and faster absolute neutrophil count recovery ( P = .03). In multivariate analysis, log Gd volume remained superior in determining which patients would have Gd signal resolution by 30 days post-HCT ( P = .016). A final analysis indicated that early Gd resolution also correlated with less neurologic progression from baseline to 1 year following HCT ( P = .006). MRI Gd volume may serve as a contributing biomarker to better delineate outcomes and an important metric in comparing therapies in the treatment of cALD.